Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
2019
Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints
2012
A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome
2009
On Discounting of Health Gains from Human Papillomavirus Vaccination: Effects of Different Approaches
2012
Non-steroidal anti-inflammatory drugs for low back pain
2008
Nonsteroidal Anti-Inflammatory Drugs for Low Back Pain
2008
Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective
2017
Mentoring in Academic Medicine
2006 Standout
Rheumatoid arthritis
2018 Standout
Bowel Disorders
2016 Standout
Psychosocial Aspects of the Functional Gastrointestinal Disorders
2006
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Periodontitis and diabetes: a two-way relationship
2011 Standout
What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D.
2003
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Kinetics of Neutrophils in Mice Exposed to Radiation and/or Granulocyte Colony-Stimulating Factor Treatment
2013
Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials
2006
The Use of Induced Pluripotent Stem Cells in Drug Development
2011 StandoutNobel
Non-specific low back pain
2016 Standout
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
2008 Standout
Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis
2010
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: Baseline results from logic (longitudinal outcomes study of gastrointestinal symptoms in Canada), a naturalistic study
2006
Discounting and decision making in the economic evaluation of health-care technologies
2010
Whither trial‐based economic evaluation for health care decision making?
2006
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
2017
Hepatocellular carcinoma
2021 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry
2007
Mentoring Undergraduate Nursing Students
2004
Irritable bowel syndrome
2016 Standout
The NICE Cost-Effectiveness Threshold
2008
Graphical Tools for Network Meta-Analysis in STATA
2013 Standout
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Impact of functional gastrointestinal disorders on health‐related quality of life: a population‐based case–control study
2004
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers
2013
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Systematic review: the efficacy of treatments for irritable bowel syndrome – a European perspective
2006
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
2008
The economic impact of irritable bowel syndrome
2003
Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands
2015
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
2021 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Irritable bowel syndrome; update on pathophysiology and management
2012
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
2016
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
2007 Standout
A taxonomy of model structures for economic evaluation of health technologies
2006
Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men’s Issue?
2019
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
2015 Standout
Rheumatoid arthritis
2010 Standout
Costs of Irritable Bowel Syndrome in the UK and US
2006
Cost-Effectiveness of Hybrid PET/CT for Staging of Non–Small Cell Lung Cancer
2010
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
The Economics of Drug Discovery and the Ultimate Valuation of Pharmacotherapies in the Marketplace
2008
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
2010
The changing landscape of biosimilars in rheumatology
2016
Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review
2008
AGA technical review on irritable bowel syndrome
2002 Standout
Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
2014 Standout
The Impact of Body Weight on Patient Utilities with or without Type 2 Diabetes: A Review of the Medical Literature
2007
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling
2006
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
2012 Standout
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
2008 Standout
A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome
2013
Hepatocellular carcinoma
2022 Standout
Societal costs for irritable bowel syndrome – a population based study
2010
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Utility values for obesity and preliminary analysis of the Health Outcomes Data Repository
2004
A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial
2009
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
2009 Standout
Assessing key assumptions of network meta‐analysis: a review of methods
2013
Endovenous thermal ablation for healing venous ulcers and preventing recurrence
2013 StandoutNobel
Multiple Sclerosis
2018 Standout
Nonpharmacologic Therapies for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline
2007 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
2006
A Re-Evaluation of Random-Effects Meta-Analysis
2008 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Evaluation of inconsistency in networks of interventions
2013
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review
2011
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Evidence Synthesis for Decision Making 2
2012
Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis.
2007
Research Prioritization Based on Expected Value of Partial Perfect Information: A Case-Study on Interventions to Increase Uptake of Breast Cancer Screening
2008
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Superficial heat or cold for low back pain
2006
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Surgery for weight loss in adults
2014 Standout
Evidence Synthesis for Decision Making 3
2013
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
2020
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
2013
Works of Ron Akehurst being referenced
Effectiveness and cost-effectiveness of prognostic markers in prostate cancer
2003
Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
2014
Cost-Effectiveness of Sibutramine in the Treatment of Obesity
2004
Choice of NSAID and Management Strategy in Rheumatoid Arthritis and Osteoarthritis
1998
Economic evaluation of everolimus versus mycophenolate mofetil in combination with cyclosporine and prednisolone in de novo renal transplant recipients
2004
The implications of contact with the mentor for preregistration nursing and midwifery students
2001
Cost-Effectiveness of Low-Level Heat Wrap Therapy for Low Back Pain
2004
Consistency between Direct and Indirect Trial Evidence: Is Direct Evidence Always More Reliable?
2011
Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion
2005
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis
2009
Health-Related Quality of Life and Cost Impact of Irritable Bowel Syndrome in a UK Primary Care Setting
2002
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
2005
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
2011
The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries
2015
Quality of life of IBS patients in the United Kingdom compared with a general population sample
2003
A Guide to Adjusting Survival Time Estimates to Account for Treatment Switching in Randomised Controlled Trials
2013
Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence
2007
Searching for a threshold – Not so…
2007
Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context
2014
Economic evaluation of everolimus versus mycophenolate mofetil in combination with cyclosporine and prednisolone in de novo renal transplant recipients
2004